FDA Encourages Development of Novel Drug Delivery Systems

Manufacturers, regulators, and public health officials are establishing new policies and expanding research initiatives to improve drug formulations and delivery systems. The US Food and Drug Administration recently approved many new products with novel delivery methods such as inhaled insulin and a depression drug transdermal patch. The agency also bolstered its staff with experts in pharmaceutical engineering and formulation to assess these challenging products.

The Critical Path Opportunities List unveiled by FDA officials in March cites "manufacturing novel dosage forms" as an area in which collaboration with industry and academia could remove roadblocks to new drug development. And, new drug formulations may eliminate complications related to managing temperature-sensitive drugs and vaccines through the distribution chain.

View Full Article